Atlas Trials

A Study on the Effection of Potassium Citrate Extended-release Tablets on Urolithiasis Formation or Recurrence

Clinical trial NCT03007160 · UNKNOWN

Trial details

NCT number
NCT03007160
Sponsor
Dawnrays Pharmaceutical (Holdings) Limited
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Urolithiasis
Start date
2016-07-01
Primary completion
2020-09-01
Enrollment
2001

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.